BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36624289)

  • 1. Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Wilk M; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Int; 2023 Apr; 43(4):687-694. PubMed ID: 36624289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
    Wilk M; Łosińska K; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Int; 2022 Apr; 42(4):669-682. PubMed ID: 35098329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual Disease Burden in Patients With Axial Spondyloarthritis and Psoriatic Arthritis Despite Low Disease Activity States in a Multiethnic Asian Population.
    Liu V; Fong W; Kwan YH; Leung YY
    J Rheumatol; 2021 May; 48(5):677-684. PubMed ID: 33132217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
    Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High pain catastrophizing scores in one-fourth of patients on biotherapy for spondylarthritis or rheumatoid arthritis.
    Penhoat M; Saraux A; Le Goff B; Augereau P; Maugars Y; Berthelot JM
    Joint Bone Spine; 2014 May; 81(3):235-9. PubMed ID: 24321439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual symptoms and disease burden among patients with psoriatic arthritis: is a new disease activity index required?
    Kilic G; Kilic E; Nas K; Kamanlı A; Tekeoglu İ
    Rheumatol Int; 2019 Jan; 39(1):73-81. PubMed ID: 30426235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of fatigue in people with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis - Results of a cross-sectional study.
    Pilgaard T; Hagelund L; Stallknecht SE; Jensen HH; Esbensen BA
    PLoS One; 2019; 14(6):e0218831. PubMed ID: 31251785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
    Benavent D; Capelusnik D; Ramiro S; Molto A; López-Medina C; Dougados M; Navarro-Compán V
    RMD Open; 2022 Sep; 8(2):. PubMed ID: 36096523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world effectiveness of golimumab in the treatment of patients with active rheumatoid arthritis, psoriatic arthritis, or axial spondyloarthritis who failed initial TNF-α inhibitor therapy: a pooled analysis of European prospective observational studie.
    Govoni M; Batalov A; Boumpas DT; D'Angelo S; De Keyser F; Flipo RM; Kellner H; Leroi H; Khalifa A
    Clin Exp Rheumatol; 2024 Mar; 42(3):642-650. PubMed ID: 37976120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
    Gossec L; Berenbaum F; Chauvin P; Hudry C; Cukierman G; de Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert JM; Saraux A
    Clin Rheumatol; 2018 Oct; 37(10):2649-2657. PubMed ID: 29948351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis.
    Zhao SS; Duffield SJ; Goodson NJ
    Best Pract Res Clin Rheumatol; 2019 Jun; 33(3):101423. PubMed ID: 31703796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
    Fornaro M; Righetti G; Abbruzzese A; Lopalco G; Cacciapaglia F; Anelli MG; Venerito V; Iannone F
    Clin Rheumatol; 2021 Sep; 40(9):3659-3665. PubMed ID: 33864158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis.
    Currado D; Biaggi A; Pilato A; Marino A; Ruscitti P; Pantano I; Di Donato S; Vomero M; Berardicurti O; Pavlych V; Di Vico C; Caso F; Costa L; Tasso M; Camarda F; Misceo F; De Vincenzo F; Corrado A; Cantatore FP; Perosa F; Guggino G; Scarpa R; Cipriani P; Ciccia F; Giacomelli R; Navarini L
    Clin Exp Rheumatol; 2023 Sep; 41(9):1856-1861. PubMed ID: 37083177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain Catastrophizing, Subjective Outcomes, and Inflammatory Assessments Including Ultrasound: Results From a Longitudinal Study of Rheumatoid Arthritis Patients.
    Hammer HB; Uhlig T; Kvien TK; Lampa J
    Arthritis Care Res (Hoboken); 2018 May; 70(5):703-712. PubMed ID: 28805018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of disease burden in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis.
    Michelsen B; Fiane R; Diamantopoulos AP; Soldal DM; Hansen IJ; Sokka T; Kavanaugh A; Haugeberg G
    PLoS One; 2015; 10(4):e0123582. PubMed ID: 25853482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower concentration of vitamin D is associated with lower DAS28 and VAS-pain scores in patients with inflammatory rheumatic diseases treated with infliximab: a pilot study.
    Miler M; Nikolac Gabaj N; Grazio S; Vahtarić A; Vrtarić A; Grubišić F; Skala Kavanagh H; Doko Vajdić I; Vrkić N
    Rheumatol Int; 2020 Sep; 40(9):1455-1461. PubMed ID: 32462255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unveiling axial involvement in psoriatic arthritis: An ancillary analysis of the ASAS-perSpA study.
    Benavent D; Plasencia C; Poddubnyy D; Kishimoto M; Proft F; Sawada H; López-Medina C; Dougados M; Navarro-Compán V
    Semin Arthritis Rheum; 2021 Aug; 51(4):766-774. PubMed ID: 34144387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of switching from reference adalimumab to SB5 in a real-life cohort of inflammatory rheumatic joint diseases.
    Bruni C; Bitti R; Nacci F; Cometi L; Tofani L; Bartoli F; Fiori G; Matucci-Cerinic M
    Clin Rheumatol; 2021 Jan; 40(1):85-91. PubMed ID: 32514676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance of Global Assessments by Patient and Physician Is Higher in Female than in Male Patients Regardless of the Physician's Sex: Data on Patients with Rheumatoid Arthritis, Axial Spondyloarthritis, and Psoriatic Arthritis from the DANBIO Registry.
    Lindström Egholm C; Krogh NS; Pincus T; Dreyer L; Ellingsen T; Glintborg B; Kowalski MR; Lorenzen T; Madsen OR; Nordin H; Rasmussen C; Hetland ML
    J Rheumatol; 2015 Oct; 42(10):1781-5. PubMed ID: 26233511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.